TELCON RF PHARMACEUTICAL. Inc.

₩1,903As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:200230Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR (33.94%)
Div yield —
ROE (32.70%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.33
PE TTM —
TSR TTM (83.29%)
Mkt cap ₩10.70B
ROIC 0.33%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩1,869
(1.78%)
89.80%
Hold 7|12|5|12|6
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
23.89
23.98
26.10
27.76
25.22%
21.31%
18.22%
20.36%
Revenue₩M
763.6
753.4
765.1
790.4
7.80%
1.56%
2.08%
2.26%
Peers (US$7.887M)
Cap (US$)
PE
7.846M
—
Capital
TTM
5Y
10Y
Leveragex
0.635
0.023
0.016
EBIT/Intx
21.76
0.359
0.330
Own earn%
154.47
62.41
38.94
Sh yield%
25.19
13.55
12.79
Owners
Insiders/Inst%
5.40
54.01
Short interest%
1.15
SBC / revenue%
1.73
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
9
Op margin range%
26–32
$1 testx
0.2
Incr. ROIC%
23